GLP-1 Market
LLY $1138.28 ▲ +2.0% NVO $43.45 ▲ +0.9% PFE $27.72 • 0.0% VKTX $31.53 ▼ -1.4% KLRA $13.75 ▼ -1.4% GPCR $38.44 ▼ -0.6% RHHBY $54.80 ▲ +3.9%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Scopolamine patch

Company
University of California, Davis
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
13 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

13 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 15, 2026

Find a Clinical Trial Near Me

See recruiting studies for Scopolamine patch and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT04366518

    Toward a Computationally-Informed, Personalized Treatment for Hallucinations

    Not yet reported Yale University 35 participants Est. completion 2032-08 1 site
    Alcohol use disorder Other conditions: Psychosis
    View official trial listing →
  • Recruiting NCT NCT04894864

    Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair

    Not yet reported University of Crete 40 participants Est. completion 2027-09-01 1 site
    Other conditions: Elective Surgical Procedures, Postoperative Pain, Anesthesia, Opioid Use, Abdominal Aortic Aneurysm Without Rupture, Vascular Surgical Procedure, Interleukin 6, Immunomodulators
    View official trial listing →
  • Recruiting NCT NCT05172739

    Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC

    Not yet reported University of Crete 70 participants Est. completion 2026-11-01 1 site
    Other conditions: Systemic Inflammatory Response Syndrome, Postoperative Pain, Acute, Postoperative Pain, Chronic, Infections Postoperative, Opioid Use, Anesthesia, Non-small Cell Lung Cancer
    View official trial listing →
  • Recruiting NCT NCT05260320

    Anesthetic Optimization in Pediatric LeFort Surgeries

    Not yet reported Johns Hopkins University 50 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Le Fort, Pain, Postoperative
    View official trial listing →
  • Recruiting NCT NCT05594017

    Pharmacological Modulation of Brain Oscillations in Memory Processing

    Not yet reported University of Texas Southwestern Medical Center 60 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Epilepsy, Seizures, Cognitive Impairment, Mild, Memory Disorders, Memory Loss
    View official trial listing →
  • Recruiting NCT NCT05634057

    Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis

    Not yet reported Chen Ying 782 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Sepsis
    View official trial listing →
  • Recruiting NCT NCT05640232

    Efficacy and Safety of CDE100 in the Treatment of Menstrual Cramp Pain Associated With Primary Dysmenorrhea

    Not yet reported EMS 238 participants Est. completion 2027-01-30 1 site
    Other conditions: Primary Dysmenorrhea
    View official trial listing →
  • Recruiting NCT NCT05719467

    SAINT: Safe Induction of Labor Trial

    Not yet reported Oslo University Hospital 3000 participants Est. completion 2027-12-31 5 sites
    Other conditions: Labor Complication, Induced; Birth, Pregnancy Related
    View official trial listing →
  • Recruiting NCT NCT05852730

    Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

    Not yet reported Repurposed Therapeutics, Inc. 80 participants Est. completion 2026-09 1 site
    Other conditions: Motion Sickness, Space, Motion Simulation, Parabolic Flight
    View official trial listing →
  • Recruiting NCT NCT06938581

    ERAS Protocols in Breast Conserving Surgery

    Not yet reported University of Nebraska 260 participants Est. completion 2029-02 1 site Stand-alone
    Other conditions: Breast Cancer, Postoperative Recovery
    View official trial listing →
  • Recruiting NCT NCT07523997

    Imaging of Endometriosis With Total-body PET-CT (PET-Endo)

    University of Edinburgh 30 participants Est. completion 2027-12-31 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Recruiting NCT NCT07558226

    Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy

    Not yet reported Fundacio Puigvert 80 participants Est. completion 2027-11-30 1 site
    Other conditions: Anesthesia, Anesthesia and Procedure Related Time Intervals, Nephrectomy / Methods
    View official trial listing →
  • Recruiting NCT NCT07814976

    Hyoscine Butylbromide During Transcystic Papillary Balloon Dilation for Choledocholithiasis

    Not yet reported Riga East Clinical University Hospital 50 participants Est. completion 2027-02-01 1 site
    Other conditions: Choledocholithiasis, Common Bile Duct Stones
    View official trial listing →
  • Terminated NCT NCT00055575

    Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies

    Not yet reported National Institute of Mental Health (NIMH) 197 participants Est. completion 2015-02-02 1 site Stand-alone
    Other conditions: Mood Disorders, Healthy, Unipolar Depression, Bipolar Depression
    View official trial listing →
  • Completed NCT NCT00122434

    Dose Finding Study in COPD

    Not yet reported Boehringer Ingelheim 389 participants 43 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00128440

    High Dose Trial in COPD

    Not yet reported Boehringer Ingelheim 78 participants 13 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00144196

    12 Week Efficacy of Tiotropium Versus Placebo in Patients With Mild COPD According to Swedish Guidelines (SPIRIMILD)

    Not yet reported Boehringer Ingelheim 224 participants Est. completion 2005-07-25 27 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00144326

    A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 250 participants Est. completion 2005-10 27 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00144339

    Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients

    Not yet reported Boehringer Ingelheim 5993 participants 490 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00157235

    Effect of Tiotropium Inhalation Capsules (Spiriva) on Exercise Tolerance in COPD Patients

    Not yet reported Boehringer Ingelheim 234 participants Est. completion 2006-04 12 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00239408

    Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

    Not yet reported Boehringer Ingelheim 311 participants Est. completion 2004-04 33 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00239447

    Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD

    Not yet reported Boehringer Ingelheim 131 participants Est. completion 2004-04-29 11 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00239460

    Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD

    Not yet reported Boehringer Ingelheim 196 participants 12 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00239499

    Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 107 participants Est. completion 2004-08 12 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00257452

    A Double-blind, Randomised Study to Assess the Influence of Tiotropium (Spiriva®)

    Not yet reported Boehringer Ingelheim 56 participants Est. completion 2005-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00274014

    Measure of the Long Term Influence of SPIRIVA® in Acute Respiratory Disorders

    Not yet reported Boehringer Ingelheim 1000 participants Est. completion 2003-10 55 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274027

    Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

    Not yet reported Boehringer Ingelheim 19 participants Est. completion 2003-03 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274040

    Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD

    Not yet reported Boehringer Ingelheim 141 participants Est. completion 2003-03 18 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274053

    Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

    Not yet reported Boehringer Ingelheim 555 participants Est. completion 2004-04 27 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274066

    Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva

    Not yet reported Boehringer Ingelheim 65 participants Est. completion 2003-09 5 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274079

    SPIRIVA in Ususal Care

    Not yet reported Boehringer Ingelheim 395 participants Est. completion 2003-10 44 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274508

    Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients

    Not yet reported Boehringer Ingelheim 261 participants 28 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274521

    Tiotropium (Spiriva) Rehabilitation Study

    Not yet reported Boehringer Ingelheim 108 participants 19 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274534

    A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

    Not yet reported Boehringer Ingelheim 36 participants Est. completion 2003-07 2 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274547

    Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 1829 participants 26 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274560

    A Multiple Dose Comparison of Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol.

    Not yet reported Boehringer Ingelheim 653 participants 50 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00274573

    Effects of Once Daily Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD) of Different Severity

    Not yet reported Boehringer Ingelheim 1639 participants 177 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00277264

    Spiriva® Assessment of FEV1 (SAFE)

    Not yet reported Boehringer Ingelheim 914 participants Est. completion 2004-05 96 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00279019

    Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported GlaxoSmithKline 31 participants Est. completion 2006-06-13 3 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00281567

    Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 76 participants 2 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00292448

    A Randomised, Double-blind, Crossover Study of Ba679BR Respimat in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 157 participants Est. completion 2007-03 27 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00308191

    A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD

    Not yet reported Dey 128 participants Est. completion 2006-12 17 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT00325169

    SERETIDE Plus Tiotropium Versus Individual Components

    Not yet reported GlaxoSmithKline 41 participants Est. completion 2006-08 5 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00350207

    Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg

    Not yet reported Boehringer Ingelheim 388 participants 109 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00359788

    A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.

    Not yet reported Boehringer Ingelheim 349 participants 31 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00361959

    SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease

    Not yet reported GlaxoSmithKline 1270 participants Est. completion 2006-02 166 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00365560

    An Efficacy and Safety Evaluation of Tiotropium add-on Therapy in Patients With Severe Persistent Asthma

    Not yet reported Boehringer Ingelheim 115 participants 16 sites
    Other conditions: Asthma
    View official trial listing →
  • Terminated NCT NCT00369915

    The Antidepressant Efficacy of the Anticholinergic Scopolamine

    Not yet reported National Institute of Mental Health (NIMH) 17 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Unipolar Depression, Bipolar Depression
    View official trial listing →
  • Completed NCT NCT00374478

    Effects of Transdermal Scopolamine on Occupational Performance

    Not yet reported Boston University 33 participants Est. completion 2006-04 1 site
    Other conditions: Motion Sickness
    View official trial listing →
  • Completed NCT NCT00387088

    Tiotropium / Respimat One Year Study in COPD.

    Not yet reported Boehringer Ingelheim 3991 participants 334 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00388882

    Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent® Inhalation Aerosol in COPD Patients.

    Not yet reported Boehringer Ingelheim 327 participants 40 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Withdrawn NCT NCT00389259

    Scopolamine Treatment for Patients With Organophosphate Poisoning

    Not yet reported Assaf-Harofeh Medical Center 50 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Neurotoxicity Syndromes
    View official trial listing →
  • Terminated NCT NCT00394485

    Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients

    Not yet reported Otsuka Pharmaceutical, Inc., Philippines 50 participants Est. completion 2008-04 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00405236

    Effect of Tiotropium on Inflammation and Exacerbations in COPD

    Not yet reported Royal Free and University College Medical School 220 participants Est. completion 2005-01 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00409890

    The Effect of Hyoscine Butyl Bromide on the First Stage of Labor in Term Pregnancies

    Not yet reported University Hospital of the West Indies 120 participants Est. completion 2005-10 1 site
    Other conditions: Labor Stage, First
    View official trial listing →
  • Completed NCT NCT00412204

    Study to Evaluate the Effects of Tiotropium Bromide on Chronic Obstructive Pulmonary Disease (COPD) During Exercise

    Not yet reported McMaster University 20 participants Est. completion 2009-04
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT00422604

    Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported GlaxoSmithKline 60 participants Est. completion 2007-05 11 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00424528

    Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Sumitomo Pharma America, Inc. 235 participants Est. completion 2007-10 28 sites
    Other conditions: Chronic Obstructive Pulmonary Disease, Bronchitis, Emphysema
    View official trial listing →
  • Completed NCT NCT00435760

    Clinical Trial to Assess Rate of Onset of Bronchodilator Action in Severe Stable Chronic Obstructive Pulmonary Disease (COPD) Patients

    Not yet reported AstraZeneca 115 participants Est. completion 2007-08 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT00463567

    26 Week Efficacy, Safety and Tolerability Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported, Not yet reported Novartis 2059 participants Est. completion 2008-08 344 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive, COPD, Lung Diseases, Obstructive
    View official trial listing →
  • Completed NCT NCT00496470

    Evaluation of Efficacy and Safety of Symbicort® as an add-on Treatment to Spiriva® in Patients With Severe COPD.

    Not yet reported AstraZeneca 660 participants Est. completion 2008-06 93 sites
    Other conditions: Chronic Obstructive Pulmonary Disease, COPD
    View official trial listing →
  • Completed NCT NCT00501852

    Efficacy and Safety of Four Doses of Glycopyrronium Bromide (NVA237) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD), in Comparison to an Active Comparator Tiotropium

    Not yet reported Novartis Pharmaceuticals 83 participants 3 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00515502

    Safety Study Using GSK573719 And Tiotropium In Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported GlaxoSmithKline 24 participants Est. completion 2007-11-06 3 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00523991

    Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

    Not yet reported Boehringer Ingelheim 457 participants 62 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00525512

    Tiotropium In Exercise

    Not yet reported Boehringer Ingelheim 519 participants 62 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive, Exercise
    View official trial listing →
  • Completed NCT NCT00528996

    An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.

    Not yet reported Boehringer Ingelheim 2080 participants Est. completion 2009-05-05 178 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00530842

    Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD

    Not yet reported Boehringer Ingelheim 344 participants 42 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00532350

    Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Novartis 22 participants Est. completion 2008-01 3 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00535366

    Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD

    Not yet reported Boehringer Ingelheim 103 participants 12 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Withdrawn NCT NCT00546234

    Tiotropium for Smoking Asthmatics Study

    Not yet reported University of Alberta Est. completion 2014-01 2 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00555022

    Effect of GSK1160724 In Healthy Volunteers

    Not yet reported GlaxoSmithKline 21 participants Est. completion 2008-04-07 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00557180

    Examining the Link Between Obesity, Inflammation, and Response to Asthma Medications

    National Jewish Health 33 participants Est. completion 2011-02 10 sites
    Other conditions: Asthma, Obesity
    View official trial listing →
  • Completed NCT NCT00563381

    Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients.

    Not yet reported Boehringer Ingelheim 7376 participants 752 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00565266

    Asthma Clinical Research Network (ACRN) Trial - Tiotropium Bromide as an Alternative to Increased Inhaled Corticosteroid in Patients Inadequately Controlled on a Lower Dose of Inhaled Corticosteroid (TALC)

    Not yet reported Milton S. Hershey Medical Center 210 participants Est. completion 2010-05 10 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00568503

    Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.

    Not yet reported Novartis 29 participants Est. completion 2008-02 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT00570544

    Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema

    Gelb, Arthur F., M.D. 29 participants Est. completion 2005-08 1 site
    Other conditions: COPD, Emphysema
    View official trial listing →
  • Completed NCT NCT00578968

    Cardiac Limitations in Chronic Obstructive Pulmonary Disease: Benefits of Bronchodilation

    Not yet reported Mayo Clinic 36 participants Est. completion 2008-08 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease, COPD
    View official trial listing →
  • Completed NCT NCT00613574

    RUSSE / Russian Spiriva® Safety & Efficacy Study

    Boehringer Ingelheim 407 participants Est. completion 2007-10 33 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT00615459

    A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control

    Not yet reported Novartis 169 participants Est. completion 2008-12 20 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT00615992

    Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines

    Boehringer Ingelheim 754 participants 73 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00624377

    Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice

    Boehringer Ingelheim 2031 participants 17 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00646061

    Pain Control in Renal Colic

    Not yet reported Seoul National University Hospital Est. completion 2008-12 1 site
    Other conditions: Renal Colic
    View official trial listing →
  • Completed NCT NCT00659737

    Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting

    Not yet reported Drexel University College of Medicine 115 participants Est. completion 2010-03 1 site
    Other conditions: Nausea, Vomiting
    View official trial listing →
  • Terminated NCT NCT00662740

    Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 220 participants Est. completion 2008-11-21 72 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00662792

    Efficacy and Safety Comparison of Tiotropium Daily + Salmeterol Daily or Twice Daily Versus Tiotropium Daily in Patients With COPD

    Not yet reported Boehringer Ingelheim 147 participants Est. completion 2009-07-22 12 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT00668772

    Tiotropium/Salmeterol Inhalation Powder in COPD

    Not yet reported Boehringer Ingelheim 207 participants Est. completion 2008-11-21 64 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00673478

    Tiotropium and Salmeterol PK Study in COPD Patients

    Not yet reported Boehringer Ingelheim 50 participants 3 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00680056

    Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients

    Not yet reported Federal University of São Paulo 33 participants Est. completion 2009-01 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive, Chronic Bronchitis, Pulmonary Emphysema
    View official trial listing →
  • Completed NCT NCT00696020

    Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)

    Not yet reported Boehringer Ingelheim 360 participants 37 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT00706446

    The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations

    Not yet reported Brigham and Women's Hospital 255 participants Est. completion 2011-09 2 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00717054

    Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting

    Not yet reported Drexel University 115 participants Est. completion 2010-03 1 site
    Other conditions: Nausea, Vomiting
    View official trial listing →
  • Completed NCT NCT00720499

    Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 141 participants 24 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00731198

    Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)

    Not yet reported Changhai Hospital 650 participants Est. completion 2009-07 4 sites
    Other conditions: ERCP, Pancreatic Diseases, Bile Duct Diseases
    View official trial listing →
  • Completed NCT NCT00737100

    Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis

    Not yet reported Boehringer Ingelheim 510 participants 107 sites
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT00740324

    Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

    Not yet reported Nihon Pharmaceutical Co., Ltd 30 participants Est. completion 2009-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00772538

    Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study I)

    Not yet reported Boehringer Ingelheim 459 participants 73 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00776984

    Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)

    Not yet reported Boehringer Ingelheim 453 participants 75 sites
    Other conditions: Asthma
    View official trial listing →
  • Terminated NCT NCT00783250

    Bronchodilators and Respiratory Mechanics in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Not yet reported IRCCS Azienda Ospedaliero-Universitaria di Bologna 20 participants Est. completion 2012-07 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00784550

    A 24-Week Study to Evaluate the Safety and Efficacy of ADVAIR DISKUS® Inhaler 250/50mcg Plus SPIRIVA HANDIHALER® Inhaler Versus SPIRIVA HANDIHALER® Inhaler Plus Placebo DISKUS® Inhaler in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

    Not yet reported GlaxoSmithKline 342 participants Est. completion 2009-12 35 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00845728

    Exacerbation Study

    Not yet reported Novartis Pharmaceuticals 3439 participants Est. completion 2012-07 423 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00846586

    Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Novartis Pharmaceuticals 1134 participants Est. completion 2010-03 137 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT00864812

    Clinical Outcomes of Tiotropium Plus Fluticasone Propionate/Salmeterol Compared With Tiotropium for Chronic Obstructive Pulmonary Disease (COPD) in Korea

    Not yet reported The Korean Academy of Tuberculosis and Respiratory Diseases 509 participants Est. completion 2010-03 32 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00868231

    Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Not yet reported AstraZeneca 30 participants Est. completion 2009-07 2 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT00870896

    The Effects of Tiotropium on the Cough Reflex in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported ThomasTruncale 5 participants Est. completion 2012-06 2 sites
    Other conditions: Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
    View official trial listing →
  • Completed NCT NCT00871182

    Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported, Not yet reported Pearl Therapeutics, Inc. 33 participants Est. completion 2009-09 6 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00877383

    Efficacy and Safety of Indacaterol Plus Tiotropium Versus Tiotropium Alone in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Novartis Pharmaceuticals 1142 participants Est. completion 2010-02 176 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT00900731

    A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 1598 participants Est. completion 2010-03 212 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00929110

    1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis 1066 participants Est. completion 2011-04 139 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00932737

    (Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis

    Not yet reported Boehringer Ingelheim 197 participants Est. completion 2010-02-08 19 sites
    Other conditions: Abdominal Pain
    View official trial listing →
  • Completed NCT NCT00939211

    The Study Will Evaluate the Effect of AZD9164 in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported AstraZeneca 25 participants Est. completion 2009-11 3 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT00950807

    GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease

    Not yet reported GlaxoSmithKline 176 participants Est. completion 2010-03-15 19 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT00981851

    Interaction in Chronic Obstructive Pulmonary Disease Experiment

    Not yet reported Radboud University Medical Center 40 participants Est. completion 2011-05 2 sites
    Cardiovascular disease Other conditions: Chronic Obstructive Pulmonary Disease, Smoking, Bronchodilation
    View official trial listing →
  • Completed NCT NCT00996697

    Differential Trough Effects of 'Triple Therapy' on Pulmonary Function in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Brian J Lipworth 23 participants Est. completion 2008-09 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT00999908

    Comparison of the Effects of Indacaterol and Tiotropium on Inspiratory Capacity

    Not yet reported Novartis Pharmaceuticals 54 participants Est. completion 2010-03 11 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01012765

    Effect of Indacaterol on Inspiratory Capacity (IC)

    Not yet reported Novartis Pharmaceuticals 173 participants 21 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01040689

    Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Boehringer Ingelheim 108 participants 15 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01040728

    A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Boehringer Ingelheim 122 participants 12 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01044342

    A Healthy Volunteer Study to Evaluate Reversibility of Induced Impairment of Cognition

    Not yet reported AstraZeneca 20 participants Est. completion 2010-04 1 site
    Other conditions: Cognition
    View official trial listing →
  • Status unknown NCT NCT01060696

    Efficacy of Mefenamic Acid and Hyoscine for Pain Relief During Saline Infusion Sonohysterography in Infertile Women

    Not yet reported Mahidol University 138 participants Est. completion 2010-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT01068613

    Safety and Efficacy of Multiple Doses of QAX028 in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Not yet reported Novartis Pharmaceuticals 62 participants Est. completion 2010-08 4 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01072396

    Effects of Tiotropium on Breathing Capacity and Exercise Limitation in Early Stages of Chronic Obstructive Pulmonary Disease

    Not yet reported Boehringer Ingelheim 126 participants Est. completion 2011-11 15 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01085045

    Study to Evaluate the Efficacy, Safety and Pharmacokinetics of PT001, PT003, and PT005 Following Chronic Dosing (7 Days) in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Pearl Therapeutics, Inc. 118 participants Est. completion 2010-11 16 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01112241

    Bronchodilator Responsiveness in Obliterative Bronchiolitis

    Not yet reported IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy 17 participants Est. completion 2010-05 1 site
    Other conditions: Obliterative Bronchiolitis
    View official trial listing →
  • Completed NCT NCT01119937

    Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients

    Not yet reported Novartis Pharmaceuticals 211 participants 40 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01120691

    Effect of QVA149 Versus NVA237 and Tiotropium on Chronic Obstructive Pulmonary Disorder (COPD) Exacerbations

    Not yet reported Novartis Pharmaceuticals 2224 participants Est. completion 2012-07 342 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01122680

    Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma

    Not yet reported Boehringer Ingelheim 105 participants 19 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01126437

    Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary Disease

    Not yet reported Boehringer Ingelheim 17183 participants Est. completion 2013-05 1191 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01152450

    A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma

    Not yet reported Boehringer Ingelheim 94 participants 15 sites
    Other conditions: Asthma
    View official trial listing →
  • Status unknown NCT NCT01172925

    Study of a Tiotropium Inhaler For Shortness of Breath in Advanced Non-Small Cell Lung Cancer

    Not yet reported Hamilton Health Sciences Corporation 34 participants Est. completion 2016-08 1 site
    Other conditions: NSCLC, Dyspnea
    View official trial listing →
  • Completed NCT NCT01176903

    Safety and Efficacy Study of Glyco pMDI After Single and Repeated Administration

    Not yet reported, Not yet reported Chiesi Farmaceutici S.p.A. 65 participants Est. completion 2011-08 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01181310

    Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 31 participants Est. completion 2007-10 Stand-alone
    Other conditions: Dementia
    View official trial listing →
  • Status unknown NCT NCT01198106

    A Double-blind Comparison of Scopolamine With Cinnarizin for Prevention of Simulator Sickness

    Not yet reported Medical Corps, Israel Defense Force 100 participants Est. completion 2010-09 1 site
    Other conditions: Simulator Sickness
    View official trial listing →
  • Completed NCT NCT01202188

    A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 2144 participants Est. completion 2012-03 166 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01213355

    Scopolamine Challenge Study

    Not yet reported Pfizer 38 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01222533

    Tiotropium Respimat Pharmacokinetic Study in COPD

    Not yet reported Boehringer Ingelheim 154 participants 11 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01233284

    Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma.

    Not yet reported Boehringer Ingelheim 149 participants 19 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01277523

    Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

    Not yet reported Boehringer Ingelheim 392 participants Est. completion 2013-10 69 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01281501

    Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole

    Not yet reported Chulalongkorn University 87 participants Est. completion 2011-10 1 site
    Other conditions: Dyspepsia, Emergency, Pain
    View official trial listing →
  • Completed NCT NCT01285492

    Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 160 participants Est. completion 2012-09 35 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01290874

    Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)

    Not yet reported Brigham and Women's Hospital 1070 participants Est. completion 2013-07 13 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01294787

    Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 85 participants Est. completion 2011-11 13 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT01307189

    Effects of Tiotropium on Walking Capacity in Patients With COPD

    Not yet reported Laval University 33 participants Est. completion 2010-08 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01309139

    Pharmacokinetics of the Fixed Dose Combination of Tiotropium Plus BI 54903 Versus the Combination of the Monoproducts of Tiotropium and BI 54903 in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 36 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01312844

    A Study of the Use of IV Scopolamine to Augment the Efficacy of Electroconvulsive Therapy (ECT)

    Not yet reported Massachusetts General Hospital 7 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT01316380

    Efficacy and Safety of 2 Doses of Tiotropium Via Respimat in Adult Patients With Mild Persistent Asthma

    Not yet reported Boehringer Ingelheim 465 participants Est. completion 2012-04 62 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01316900

    24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease

    Not yet reported GlaxoSmithKline 846 participants Est. completion 2012-04-24 97 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01316913

    24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease

    Not yet reported GlaxoSmithKline 872 participants Est. completion 2012-04 100 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01331694

    Outcomes and Costs Associated With Initiating Maintenance Treatment With Fluticasone Propionate 250mcg/Salmeterol Xinafoate 50mcg Combination (FSC) Versus Anticholinergics Including Tiotropium (TIO) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    GlaxoSmithKline 76130 participants Est. completion 2010-05
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01332461

    Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies

    GlaxoSmithKline 5677 participants Est. completion 2010-05
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01337336

    Chronic Obstructive Pulmonary Disease (COPD)-Related Outcomes and Costs for Patients on Combination Fluticasone Propionate-Salmeterol Xinafoate 250/50mcg Versus Anticholinergics in a COPD-Comorbid Depression/Anxiety Population

    GlaxoSmithKline 1 participants Est. completion 2011-03
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT01345864

    Assessment Of The Effects Of Single Doses Of An Investigational Drug, Given Alone Or With Donepezil, On Scopolamine-Induced Changes In Memory And Learning In Healthy Adults

    Not yet reported Pfizer 88 participants Est. completion 2011-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01355991

    Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI

    Not yet reported James J. Peters Veterans Affairs Medical Center 40 participants Est. completion 2016-08 2 sites
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT01372410

    A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported GlaxoSmithKline 163 participants Est. completion 2011-10-27 13 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01379001

    Assessment of Cholinergic and Cognitive Function Using Pharmacologic ASL-Perfusion MRI

    Not yet reported Hebrew SeniorLife 60 participants Est. completion 2013-01 Stand-alone
    Other conditions: Cholinergic Function
    View official trial listing →
  • Completed NCT NCT01381406

    Impact of Initiating Tiotropium Alone Versus Initiating Tiotropium in Combination With Fluticasone Propionate/Salmeterol Xinafoate Combination (FSC) on Chronic Obstructive Pulmonary Disease-related Outcomes in Patients With Pre-existing Exacerbations

    GlaxoSmithKline 3333 participants Est. completion 2010-09
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01383499

    A Study to Evaluate Efficacy and Safety of Tiotropium in Children 6 to 11 Years Old With Moderate Asthma

    Not yet reported Boehringer Ingelheim 101 participants Est. completion 2012-09 24 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01387178

    Outcomes From Initial Maintenance Therapy With Fluticasone Propionate 250/Salmeterol 50 (FSC) or Tiotropium in Chronic Obstructive Pulmonary Disease

    GlaxoSmithKline 22223 participants Est. completion 2010-02
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01395875

    Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment

    GlaxoSmithKline 2849 participants Est. completion 2011-06
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01395888

    A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD

    Not yet reported GlaxoSmithKline 260 participants Est. completion 2012-08-06 55 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01397890

    Efficacy and Tolerability of Symbicort as an add-on Treatment to Spiriva Compare With Spiriva Alone in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported AstraZeneca 793 participants Est. completion 2013-06 31 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01399710

    Impact of Computer-Aided Detection (CAD) as Second Reader in CT Colonography

    Not yet reported im3D S.p.A. 651 participants Est. completion 2010-03
    Other conditions: Individuals With Suspected Colorectal Disease
    View official trial listing →
  • Completed NCT NCT01426009

    Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study

    Not yet reported Sunovion Respiratory Development Inc. 140 participants Est. completion 2011-12 11 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01431274

    Tiotropium+Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 2624 participants Est. completion 2013-09 239 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01431287

    Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 2539 participants Est. completion 2013-11 240 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01437748

    Closing Volume Interpretation and Bronchodilators Effect

    Not yet reported University of Milan 40 participants Est. completion 2014-09 1 site
    Other conditions: Healthy, COPD
    View official trial listing →
  • Completed NCT NCT01455129

    Tiotropium In Early Chronic Obstructive Pulmonary Disease Patients in China

    Not yet reported The First Affiliated Hospital of Guangzhou Medical University 841 participants Est. completion 2016-08 25 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01462929

    Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported AstraZeneca 414 participants Est. completion 2012-05 41 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Status unknown NCT NCT01465906

    Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease

    Not yet reported Shanghai Zhongshan Hospital 160 participants Est. completion 2011-11 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Status unknown NCT NCT01466712

    Evaluate the Effects of Formoterol and Beclomethasone Dipropionate Combination Therapy on Small Airways Function

    Not yet reported KU Leuven 20 participants Est. completion 2014-12 1 site
    Other conditions: COPD, Emphysema, Small Airway Disease
    View official trial listing →
  • Completed NCT NCT01483625

    Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory Infection

    Not yet reported Boehringer Ingelheim 140 participants Est. completion 2012-12 27 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01490125

    The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 247 participants Est. completion 2012-08 43 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01498081

    A Single-dose Study to Investigate the Effects of 3 Different Doses of Inhaled AZD2115 in COPD Patients

    Not yet reported AstraZeneca 39 participants Est. completion 2012-10 6 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT01513460

    Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Novartis Pharmaceuticals 773 participants Est. completion 2013-12 71 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01525615

    A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD

    Not yet reported Boehringer Ingelheim 404 participants Est. completion 2013-09 60 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01533922

    Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients

    Not yet reported Boehringer Ingelheim 295 participants Est. completion 2013-11 44 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01533935

    Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.

    Not yet reported Boehringer Ingelheim 291 participants Est. completion 2013-11 33 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01559116

    Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary Disease

    Not yet reported Boehringer Ingelheim 219 participants Est. completion 2013-08 29 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01566773

    PT001 MDI Versus Spiriva® in Patients With Moderate to Severe COPD

    Not yet reported Pearl Therapeutics, Inc. 140 participants Est. completion 2012-08 10 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01574651

    The Effect of QVA149 on Health Related Quality of Life in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 934 participants Est. completion 2013-04 144 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01592708

    Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery

    Not yet reported University of North Carolina, Chapel Hill 233 participants Est. completion 2014-04 1 site
    Other conditions: Post-operative Nausea, Post-operative Vomiting, Nausea Persistent
    View official trial listing →
  • Status unknown NCT NCT01609855

    Does the Hyoscine N-Butylbromide Administered During Colonoscopy Increase the Adenoma Detection Rate?

    Not yet reported Valduce Hospital 400 participants Est. completion 2012-06 2 sites
    Other conditions: Colonic Adenomas
    View official trial listing →
  • Completed NCT NCT01610037

    Comparison of Long-term Safety of the Combination Product QVA149A Against Placebo and Standard of Care Treatment in Chronic Obstructive Pulmonary Disease Patients With Moderate to Severe Airflow Limitation

    Not yet reported Novartis Pharmaceuticals 1215 participants Est. completion 2015-02 116 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01613326

    Efficacy, Safety, and Tolerability of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 657 participants Est. completion 2013-01 77 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Withdrawn NCT NCT01613820

    Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder

    Not yet reported Massachusetts General Hospital Est. completion 2017-02 1 site Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT01627327

    Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate/Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once Daily Compared With Tiotropium Bromide Inhalation Powder 18mcg Once Daily in Subjects With COPD Who Have or Are At Risk for Co-morbid Cardiovascular Disease

    Not yet reported GlaxoSmithKline 623 participants Est. completion 2012-12-21 54 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01634113

    Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

    Not yet reported Boehringer Ingelheim 102 participants Est. completion 2014-12 33 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01634139

    Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

    Not yet reported Boehringer Ingelheim 403 participants Est. completion 2015-12 79 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01634152

    Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

    Not yet reported Boehringer Ingelheim 401 participants Est. completion 2015-05 94 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01644838

    Effect of Hyoscine and Promethazine on Labor Pain

    Not yet reported, Not yet reported Mashhad University of Medical Sciences 93 participants Est. completion 2011-04
    Other conditions: Labor Pain
    View official trial listing →
  • Completed NCT NCT01656005

    Beta Blocker Therapy in Moderate to Severe COPD

    Not yet reported University of Dundee 18 participants Est. completion 2016-07 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01657747

    Whole-body Diffusion MRI for Staging, Response Prediction and Detecting Tumor Recurrence in Patients With Ovarian Cancer

    Not yet reported Universitaire Ziekenhuizen KU Leuven 350 participants Est. completion 2015-03 1 site
    Other conditions: Ovarian Carcinoma
    View official trial listing →
  • Completed NCT NCT01662986

    Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2

    Not yet reported Boehringer Ingelheim 79 participants Est. completion 2014-04-01 50 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01663987

    Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1

    Not yet reported Boehringer Ingelheim 79 participants Est. completion 2014-05-01 50 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01693003

    Indacaterol Versus Tiotropium on Dynamic Hyperinflation in COPD

    Not yet reported Irmandade Santa Casa de Misericórdia de Porto Alegre 20 participants Est. completion 2013-10 2 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01694771

    Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

    Not yet reported Boehringer Ingelheim 1134 participants Est. completion 2013-08 90 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01696058

    Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®

    Not yet reported Boehringer Ingelheim 1137 participants Est. completion 2013-10 94 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01696071

    Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

    Not yet reported Boehringer Ingelheim 98 participants Est. completion 2013-06 22 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT01703845

    A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.

    Not yet reported Boehringer Ingelheim 32 participants Est. completion 2013-03 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT01708057

    A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Not yet reported AstraZeneca 3 participants Est. completion 2012-12 6 sites
    Other conditions: Chronic Obstructive Pulmonary Disease, COPD
    View official trial listing →
  • Withdrawn NCT NCT01715311

    Comparison of Indacaterol With That of Placebo in 'Maintenance naïve' Patients With COPD Using Blinded Tiotropium as Active Control

    Not yet reported Novartis Pharmaceuticals Est. completion 2013-09
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01727024

    Study Evaluating Preference, Satisfaction And Correct Use Of Inhalers In COPD Patients

    Not yet reported Novartis Pharmaceuticals 140 participants Est. completion 2015-11 10 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT01734902

    Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers

    Not yet reported Boehringer Ingelheim 30 participants Est. completion 2012-12-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01751113

    A 3 Way Cross-over Study Evaluating the Effects of ADOAIR Twice Daily Plus Tiotropium Bromide Once Daily Compared With the Individual Treatments of Japanese Subjects

    Not yet reported GlaxoSmithKline 53 participants Est. completion 2013-11 3 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01762800

    Evaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcg

    Not yet reported GlaxoSmithKline 407 participants Est. completion 2015-09 39 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01777334

    The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

    Not yet reported GlaxoSmithKline 905 participants Est. completion 2013-09-24 70 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Status unknown NCT NCT01854073

    Hyoscine Butyl Bromide for Management of Prolonged Labor

    Not yet reported Ain Shams University 500 participants Est. completion 2017-06 1 site
    Other conditions: Prolonged Labor
    View official trial listing →
  • Completed NCT NCT01899742

    The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium

    Not yet reported GlaxoSmithKline 497 participants Est. completion 2015-07-22 64 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01900301

    Generalization of Extinction Learning

    Not yet reported University of California, Los Angeles 60 participants Est. completion 2017-08 1 site Stand-alone
    Other conditions: Social Anxiety Disorder
    View official trial listing →
  • Completed NCT NCT01911364

    Efficacy of Fixed Combination of Beclometasone + Formoterol + Glycopyrrolate in Chronic Obstructive Pulmonary Disease

    Not yet reported Chiesi Farmaceutici S.p.A. 3686 participants Est. completion 2016-03 3 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01922271

    Efficacy of NVA237 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Novartis Pharmaceuticals 152 participants Est. completion 2014-01 14 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT01929044

    Efficacy of Buscopan® in Comparison With 654-II (Anisodamine) in Acute Gastric or Intestinal Pain

    Not yet reported Boehringer Ingelheim 299 participants Est. completion 2015-02 20 sites
    Other conditions: Intestinal Diseases
    View official trial listing →
  • Completed NCT NCT01937390

    Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD)

    Boehringer Ingelheim 645 participants Est. completion 2016-10-22 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01959516

    Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD

    Not yet reported Novartis Pharmaceuticals 124 participants Est. completion 2014-10 21 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT01964352

    Tiotropium + Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 1)

    Not yet reported Boehringer Ingelheim 813 participants Est. completion 2014-11 77 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT01969721

    Characterization of Lung Function Profile of Inhaled Tiotropium + Olodaterol Fixed Dose Combination Compared to Fluticasone Propionate + Salmeterol Fixed Dose Combination in COPD Patients

    Not yet reported Boehringer Ingelheim 229 participants Est. completion 2015-02 29 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02006732

    Tiotropium+Olodaterol Fixed Dose Combination (FDC) in Chronic Obstructive Pulmonary Disease (OTEMTO 2)

    Not yet reported Boehringer Ingelheim 809 participants Est. completion 2014-11 78 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Status unknown NCT NCT02008162

    Bronchoreversibility and Radiologic Morphology of Emphysema

    University of Rome Tor Vergata 60 participants 1 site
    Other conditions: Emphysema, COPD
    View official trial listing →
  • Completed NCT NCT02009306

    Nasal Fentanyl and Buccal Midazolam for Dying Patients

    Not yet reported Gloucestershire Hospitals NHS Foundation Trust 20 participants Est. completion 2018-02-28 1 site
    Other conditions: Terminal Cancer
    View official trial listing →
  • Completed NCT NCT02030535

    Study to Evaluate the Effect on Lung Function and ECG When a Combination of Tiotropium Plus Olodaterol is Administered to Patients With COPD Either From a Single Inhaler or Each Compound is Administered After Each Other From Two Different Inhalers

    Not yet reported Boehringer Ingelheim 53 participants Est. completion 2014-06 6 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02033707

    Effects of Hallucinogens and Other Drugs on Mood and Performance

    Not yet reported Johns Hopkins University 20 participants Est. completion 2019-02 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02039011

    Ultra-long Acting Bronchodilator Therapy in Asthmatics

    Not yet reported University of Dundee 14 participants Est. completion 2016-07 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02039050

    Evaluation of Long-Acting Muscarinic Antagonists in COPD

    Not yet reported University of Dundee 15 participants Est. completion 2015-07 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02051335

    Roflumilast and Donepezil to Reverse Scopolamine Induced Cognitive Deficits in Healthy Adults

    Not yet reported AstraZeneca 27 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Memory Impairment, Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT02059434

    Two-part Pharmacokinetic and Pharmacodynamic Study of LAS190792 in Patients With Asthma and COPD

    Not yet reported AstraZeneca 55 participants Est. completion 2014-10-06 2 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD), Asthma
    View official trial listing →
  • Completed NCT NCT02085161

    To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

    Not yet reported Boehringer Ingelheim 304 participants Est. completion 2015-10 34 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02098889

    Safety Study of Hyoscine N Butyl Bromide in Active Management of Labor

    Not yet reported Sisli Hamidiye Etfal Training and Research Hospital 382 participants Est. completion 2012-11 1 site
    Other conditions: Labor Fast
    View official trial listing →
  • Suspended NCT NCT02103166

    Role of Hyoscine Bromide in Latent and Active Labor

    Not yet reported Hospital Clinic of Barcelona 180 participants Est. completion 2018-04 1 site
    Other conditions: Labor, First Stage
    View official trial listing →
  • Completed NCT NCT02125734

    Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients

    Not yet reported Novartis Pharmaceuticals 88 participants Est. completion 2015-01 18 sites
    Other conditions: Chronic Obstructive Pulmonary Disease, COPD
    View official trial listing →
  • Terminated NCT NCT02155309

    Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray

    Not yet reported, Not yet reported Repurposed Therapeutics, Inc. 63 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Motion Sickness
    View official trial listing →
  • Completed NCT NCT02172287

    Multiple Dose Comparison of Tiotropium Inhalation Capsules, Salmeterol Inhalation Aerosol and Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 623 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02172339

    The Pharmacokinetic, Safety and Tolerability of Tiotropium in Outpatients With Renal Impairment in Comparison to Healthy Subjects

    Not yet reported Boehringer Ingelheim 24 participants
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT02172352

    Dose Ranging Study of Ba 679 BR Inhalation Powder in Chronic Obstructive Pulmonary Disease (COPD) Patients

    Not yet reported Boehringer Ingelheim 28 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02172417

    Tiotropium in Combination With Concomitant Cimetidine or Ranitidine in Healthy Male and Female Subjects

    Not yet reported Boehringer Ingelheim 18 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02172482

    Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Boehringer Ingelheim 63127 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02172495

    Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD) in Daily Practice

    Boehringer Ingelheim 4700 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02172521

    Effect of Spiriva® 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Proven Hyperinflation

    Boehringer Ingelheim 1536 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02172547

    Effect of Spiriva® on Health-related Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Who Stopped Smoking During Treatment.

    Boehringer Ingelheim 10821 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02172560

    A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler

    Boehringer Ingelheim 441 participants 19 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02172794

    Tiotropium Inhalation Capsules and Salmeterol Inhalation Aerosol on Muscular Efficiency and Resting Energy Expenditure (REE) in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 48 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02175342

    Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Respimat Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 202 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02177318

    Tiotropium in the Treatment of the Patients With Chronic Obstructive Pulmonary Disease

    Boehringer Ingelheim 3588 participants 418 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02196194

    A Prescription-Event Monitoring (PEM) Study of Tiotropium

    Boehringer Ingelheim 13891 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Terminated NCT NCT02202369

    Multimodal Analgesia vs. Routine Care Pain Management for Lumbar Spine Fusion Surgery: A Prospective Randomized Study

    Not yet reported OrthoCarolina Research Institute, Inc. 50 participants Est. completion 2020-09-12 1 site Stand-alone
    Other conditions: Single Level Lumbar Decompression and Fusion Spine Surgery
    View official trial listing →
  • Withdrawn NCT NCT02203474

    A Study of 3 Doses of Tiotropium Hydrofluoralkane (HFA) Breath Actuated Inhaler (BAI), in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. Est. completion 2014-08
    Other conditions: Chronic Obstructive Pulmonary Disease, COPD
    View official trial listing →
  • Completed NCT NCT02207829

    A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary Disease

    Not yet reported GlaxoSmithKline 1017 participants Est. completion 2015-06-15 99 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02229786

    Efficacy and Tolerability of Buscopan Plus in Painful Gastric or Intestinal Spasms

    Not yet reported Boehringer Ingelheim 1637 participants
    Other conditions: Gastrointestinal Diseases
    View official trial listing →
  • Completed NCT NCT02231177

    Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 47 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02238119

    Efficacy and Safety of Free Combination of Tiotropium + Formoterol Compared to Formoterol and Tiotropium in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 74 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02242253

    Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 97 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02242266

    Pharmacokinetics and Safety Comparison of Tiotropium Inhalation Powder Administered as the Bromide Salt From Hard Polyethylene Capsule Via the HandiHaler® 2 and Spiriva® HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Boehringer Ingelheim 121 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02242279

    Study to Evaluate Efficacy and Safety of Inhaled BEA 2180 BR in COPD Patients

    Not yet reported Boehringer Ingelheim 37 participants
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02242292

    Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort

    Not yet reported Boehringer Ingelheim 527 participants
    Other conditions: Colic
    View official trial listing →
  • Completed NCT NCT02242305

    Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Tablets for the Treatment of Occasional or Recurrent Episodes of Gastric or Intestinal Spasm-like Pain or Discomfort

    Not yet reported Boehringer Ingelheim 302 participants Est. completion 2009-07-20
    Other conditions: Abdominal Pain
    View official trial listing →
  • Completed NCT NCT02254174

    Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 36 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02257385

    Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium

    Not yet reported GlaxoSmithKline 967 participants Est. completion 2015-05-04 84 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02257463

    Effect of Inspiratory Muscle Training on Exercise Performance and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Mansoura University 60 participants Est. completion 2014-04
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02259946

    Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 48 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02259959

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 36 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02261077

    Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 60 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02263976

    Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male Subjects

    Not yet reported Boehringer Ingelheim 101 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02273895

    The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study

    Not yet reported Mentis Cura 29 participants Est. completion 2010-01
    Other conditions: AD
    View official trial listing →
  • Terminated NCT NCT02275481

    A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) Subjects

    Not yet reported Sumitomo Pharma America, Inc. 66 participants Est. completion 2016-09-14 28 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT02276222

    A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD

    Not yet reported Sunovion Respiratory Development Inc. 1087 participants Est. completion 2016-02 118 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT02296138

    Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.

    Not yet reported Boehringer Ingelheim 7903 participants Est. completion 2017-03-29 818 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02331940

    Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD Patients

    Not yet reported University of Crete 200 participants Est. completion 2014-09
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02347072

    24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo

    Not yet reported Pearl Therapeutics, Inc. 80 participants Est. completion 2016-03-01
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT02382510

    Multiple Ascending Dose Study of TRN-157 in Stable Mild and Moderate Asthmatics

    Not yet reported Theron Pharmaceuticals, Inc. 59 participants Est. completion 2016-03 7 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02410460

    Anesthetics in Rhytidoplasty - A Comparison Study

    Not yet reported Mercy Facial Plastic Surgery Center 30 participants Est. completion 2014-06 1 site
    Other conditions: Rhytidoplasty
    View official trial listing →
  • Completed NCT NCT02441114

    Pharmacokinetics of Co-administration of Seretide 250 Diskus (HCP0910) and Spiriva Capsule for Inhalation (HGP1011)

    Not yet reported Seoul National University Hospital 10 participants Est. completion 2015-10 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02467452

    Non Inferiority of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) Versus Combination of Fluticasone Furoate (FlF)/Vilanterol (VI) + Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Chiesi Farmaceutici S.p.A. 1479 participants Est. completion 2017-01 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02473237

    Efficacy in Walked Distance of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass (EMERALD)

    Not yet reported National Institute of Respiratory Diseases, Mexico 40 participants Est. completion 2015-08 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT02479581

    The Safety and Efficacy of the Enhanced Recovery After Surgery(ERAS)Applied on Cardiac Surgery With Cardiopulmonary Bypass

    Not yet reported Xiangya Hospital of Central South University 226 participants Est. completion 2017-05 1 site Stand-alone
    Other conditions: Valvular Heart Disease
    View official trial listing →
  • Completed NCT NCT02489981

    Specific Use-result Surveillance of Spiriva Respimat in Asthmatics

    Boehringer Ingelheim 359 participants Est. completion 2017-09-28 1 site
    Other conditions: Asthma
    View official trial listing →
  • Status unknown NCT NCT02508142

    Analgesic Efficacy of Intravenous Hyoscine-N-Butylbromide (HNB) in Abdominal Colic Associated With Acute Gastroenteritis

    Not yet reported Kocaeli University 126 participants Est. completion 2016-08 1 site
    Other conditions: Abdominal Cramps
    View official trial listing →
  • Completed NCT NCT02515474

    Comparison of LCBDE vs ERCP + LC for Choledocholithiasis

    Not yet reported Hepatopancreatobiliary Surgery Institute of Gansu Province 1000 participants Est. completion 2024-01-01 12 sites
    Other conditions: Choledocholithiasis
    View official trial listing →
  • Completed NCT NCT02516098

    Determine the Bioequivalence of Two Formulations of Hyoscine Butylbromide.

    Not yet reported Boehringer Ingelheim 56 participants Est. completion 2015-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02518139

    A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Mylan Inc. 1060 participants Est. completion 2017-06 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT02541006

    Comparison of 24 Hour Bronchodilator Efficacy of Tiotropium 18 mcg Delivered Via DISCAIR Versus SPIRIVA 18 µg Delivered Via HANDIHALER® in Patients With Moderate to Severe COPD

    Not yet reported Neutec Ar-Ge San ve Tic A.Ş 58 participants Est. completion 2015-08
    Other conditions: COPD
    View official trial listing →
  • Status unknown NCT NCT02546297

    Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis

    Not yet reported Shanghai Pulmonary Hospital, Shanghai, China 90 participants Est. completion 2021-03-01 1 site
    Other conditions: COPD, Bronchiectasis
    View official trial listing →
  • Status unknown NCT NCT02546349

    Exhaled NO Based Treatment of Chronic Obstructive Pulmonary Disease (COPD), ICS/LABA Versus LAMA

    Not yet reported Taipei Veterans General Hospital, Taiwan 143 participants Est. completion 2016-01 1 site
    Other conditions: COPD
    View official trial listing →
  • Status unknown NCT NCT02557087

    Hyoscine ButylBromide for Intrapartum Analgesia

    Not yet reported Ain Shams Maternity Hospital 104 participants Est. completion 2016-03
    Other conditions: Analgesia, Obstetrical
    View official trial listing →
  • Completed NCT NCT02566031

    A Randomized, Multicenter, Open-label, Parallel-group, 12-week Study to Assess the Efficacy and Safety of Switching From Tiotropium to QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) in Symptomatic Mild to Moderate COPD Patients

    Not yet reported Novartis Pharmaceuticals 379 participants Est. completion 2018-06-04 24 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT02567214

    Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD

    Not yet reported Laval University 50 participants Est. completion 2018-11-30 3 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT02573155

    Two-part Safety, Tolerability, Pharmacodynamic and -Kinetic Study of Inhaled AZD8871 in Asthmatic and COPD Subjects

    Not yet reported AstraZeneca 134 participants Est. completion 2016-08 2 sites
    Other conditions: Asthma (Part 1), COPD (Part 2)
    View official trial listing →
  • Completed NCT NCT02582307

    Buscopan Versus Acetaminophen for Acute Abdominal Pain in Children

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 236 participants Est. completion 2019-02-22 1 site
    Other conditions: Abdomen, Acute, Children
    View official trial listing →
  • Completed NCT NCT02586649

    24hr Effects of Tiotropium Bromide in Tetraplegia

    Not yet reported James J. Peters Veterans Affairs Medical Center 10 participants Est. completion 2019-12 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT02603393

    Evaluation of the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD

    Not yet reported Novartis Pharmaceuticals 1053 participants Est. completion 2017-07-18 167 sites
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT02613494

    Clozapine-induced Hypersalivation - Feasibility Trial

    Not yet reported, Not yet reported Mersey Care NHS Trust 29 participants Est. completion 2018-02-23 2 sites
    Other conditions: Sialorrhea
    View official trial listing →
  • Completed NCT NCT02618785

    Antispasmodic Drug for Diagnosis Proximal Tubal Occlusion on Hysterosalpingography

    Not yet reported Mahidol University 146 participants Est. completion 2017-04 1 site
    Other conditions: Tubal Obstruction
    View official trial listing →
  • Completed NCT NCT02622243

    Duration of Long Acting Muscarinic Antagonist (LAMA) Bronchoprotection Against Methacholine Challenge

    Not yet reported University of Saskatchewan 13 participants Est. completion 2016-03 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02625181

    Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

    Not yet reported Vanderbilt University 27034 participants Est. completion 2017-11-30 1 site Stand-alone
    Other conditions: Postoperative Nausea and Vomiting
    View official trial listing →
  • Completed NCT NCT02627625

    Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Two Reference Products

    Not yet reported Solventum US LLC 31 participants Est. completion 2016-06 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02629965

    Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD Patients

    Not yet reported Boehringer Ingelheim 184 participants Est. completion 2017-04-17 43 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02676297

    Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products

    Not yet reported Solventum US LLC 26 participants Est. completion 2016-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02682862

    Ultra-long Acting Bronchodilator Therapy in Smoking Asthmatics

    Not yet reported University of Dundee 17 participants Est. completion 2019-05-22 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02683109

    Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD

    Not yet reported Boehringer Ingelheim 221 participants Est. completion 2017-01-30 22 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02709603

    Hyoscine Butyl Bromide in Reducing Pain During HSG

    Not yet reported Assiut University 200 participants Est. completion 2016-06 2 sites
    Other conditions: Pain Relief With HSG
    View official trial listing →
  • Completed NCT NCT02710305

    Oral Hyoscine Butyl Bromide With Cervical Lidocaine Cream in Reducing Pain During Hysterosalpingography

    Not yet reported Assiut University 140 participants Est. completion 2016-12 1 site
    Other conditions: Pain Relief
    View official trial listing →
  • Completed NCT NCT02714231

    Oral Diclofenac Sodium Versus Oral Hyoscine Butyl Bromide During Intrauterine Device Insertion

    Not yet reported Assiut University 100 participants Est. completion 2017-03 1 site
    Other conditions: Family Planning
    View official trial listing →
  • Completed NCT NCT02714699

    Oral Hyoscine Butyl Bromide Versus Diclofenac Potassium Before Office Hysteroscopy

    Not yet reported, Not yet reported Assiut University 129 participants Est. completion 2017-05 1 site
    Other conditions: Endoscopy
    View official trial listing →
  • Status unknown NCT NCT02719119

    Trial of Monthly Versus Bi-weekly Endoscopic Variceal Ligation for the Prevention of Esophageal Variceal Rebleeding

    Not yet reported West China Hospital 60 participants Est. completion 2018-02 1 site
    Other conditions: Esophageal and Gastric Varices
    View official trial listing →
  • Status unknown NCT NCT02725398

    Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser Endomicroscopy

    Not yet reported Xijing Hospital of Digestive Diseases 150 participants Est. completion 2016-12 1 site
    Other conditions: Gastrointestinal Imaging With pCLE
    View official trial listing →
  • Completed NCT NCT02796677

    AMPLIFY - D6571C00001 Duaklir USA Phase III Study

    Not yet reported AstraZeneca 1595 participants Est. completion 2017-06-08 163 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02811341

    The Application of Spasmolytic in PCLE Examination of Superior Gastrointestinal Endoscope

    Not yet reported Shandong University 122 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Using Copolamine Butylbromide in Probe-based Confocal Laser Endomicroscopy for Gastroendoscopy Examination
    View official trial listing →
  • Withdrawn NCT NCT02812862

    Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD

    Not yet reported RWTH Aachen University Est. completion 2018-08 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT02824679

    Effect of Intravenous Hyoscine Butylbromide Injection on First Stage Labour in Primigavidae

    Not yet reported Ahmed M Maged, MD 200 participants Est. completion 2017-03
    Other conditions: Vaginal Delivery
    View official trial listing →
  • Completed NCT NCT02839135

    A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.

    Not yet reported GlaxoSmithKline 128 participants Est. completion 2016-08-10 1 site Stand-alone
    Other conditions: Motion Sickness
    View official trial listing →
  • Completed NCT NCT02839213

    The Effect of Hyoscine Butylbromide on Shortening of First and Second Stages of Labor

    Not yet reported Woman's Health University Hospital, Egypt 400 participants Est. completion 2016-06 1 site
    Other conditions: Labor
    View official trial listing →
  • Completed NCT NCT02845752

    The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary Disease

    Not yet reported Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 14 participants Est. completion 2018-08-06 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02849639

    The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression

    Not yet reported Daniela Moga 90 participants Est. completion 2021-04-21 1 site
    Other conditions: Alzheimer's Disease, Dementia
    View official trial listing →
  • Completed NCT NCT02853123

    Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients

    Not yet reported Boehringer Ingelheim 106 participants Est. completion 2017-08-14 13 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02864407

    Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary Disease

    Boehringer Ingelheim 3223 participants Est. completion 2021-01-20 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02872090

    Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Centre Hospitalier Universitaire de Besancon 42 participants Est. completion 2021-06-01 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT02910167

    Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima

    Boehringer Ingelheim 360 participants Est. completion 2017-02-20 1 site
    Other conditions: Acute Pain, Dysmenorrhea
    View official trial listing →
  • Terminated NCT NCT02918266

    TAK-071 Scopolamine-Induced Cognitive Impairment Study

    Not yet reported Takeda 18 participants Est. completion 2017-08-08 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02925260

    MRI in Normal Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI Pouchography

    London North West Healthcare NHS Trust 19 participants Est. completion 2019-04-01 1 site
    Other conditions: Colitis, Ulcerative, Ileal Pouches
    View official trial listing →
  • Completed NCT NCT02960113

    Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section

    Not yet reported Rutgers, The State University of New Jersey 240 participants Est. completion 2021-09 1 site Stand-alone
    Other conditions: Nausea, Vomiting, Satisfaction
    View official trial listing →
  • Status unknown NCT NCT02968082

    The Effects of Preoperative Scopolamine Patch Application on the Postoperative Nausea and Vomiting in MVD Surgery

    Not yet reported Seoul National University Hospital 60 participants Est. completion 2017-10 Stand-alone
    Other conditions: Patients
    View official trial listing →
  • Completed NCT NCT02969317

    Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients

    Not yet reported Boehringer Ingelheim 12 participants Est. completion 2017-06-15 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT02988869

    Tiotropium/Formoterol Via Discair® vs Tiotropium Monotherapy or Tiotropium + Formoterol Free Combination Treatment

    Not yet reported Neutec Ar-Ge San ve Tic A.Ş 84 participants Est. completion 2017-08 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT03028142

    The Effects of RPL554 in Addition to Tiotropium in COPD Patients

    Not yet reported Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 30 participants Est. completion 2017-08
    Other conditions: Chronic Obstructive Pulmonary Disease Moderate
    View official trial listing →
  • Completed NCT NCT03029650

    Scopolamine Patch Pharmacokinetics in Healthy Adults

    Not yet reported University of Iowa 26 participants Est. completion 2018-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03030105

    Study to Evaluate the Effects of BPN14770 on Scopolamine-induced Cognitive Impairment in Healthy Volunteers

    Not yet reported Tetra Discovery Partners 38 participants Est. completion 2017-06 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT03055390

    Effect of Intravenous Hyoscine Butylbromide Injection on Labour in High Risk Women

    Not yet reported Cairo University 300 participants Est. completion 2022-02-03 1 site
    Other conditions: Vaginal Delivery
    View official trial listing →
  • Completed NCT NCT03055988

    Cardiovascular Function in COPD Patients

    Not yet reported Boehringer Ingelheim 76 participants Est. completion 2018-03-26 10 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03083067

    Salvational Intervention for Reducing AECOPD Under Severe Air Pollution

    Not yet reported Peking University First Hospital 402 participants Est. completion 2022-03-16 11 sites
    Other conditions: COPD Exacerbation, Air Pollution
    View official trial listing →
  • Completed NCT NCT03084796

    A 6-week Dose Ranging Study of CHF 5259 pMDI in Subjects With Chronic Obstructive Pulmonary Disease

    Not yet reported Chiesi Farmaceutici S.p.A. 733 participants Est. completion 2018-06-06 112 sites
    Other conditions: COPD, Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT03095456

    Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD

    Not yet reported Mylan Inc. 207 participants Est. completion 2017-11-25 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease, COPD, Low Peak Inspiratory Flow Rate (PIFR)
    View official trial listing →
  • Completed NCT NCT03097380

    PET Study to Determine Muscarinic Receptor Occupancy in Lungs After Inhalation of AZD2115 and Tiotropium

    Not yet reported AstraZeneca 19 participants Est. completion 2017-12-30 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03118765

    Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Glenmark Specialty S.A. 155 participants Est. completion 2017-07-31 25 sites
    Other conditions: Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Completed NCT NCT03131050

    Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD

    Not yet reported Capital Medical University 66 participants Est. completion 2018-03-08 1 site Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT03137992

    Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

    Not yet reported Lupin, Inc. 377 participants Est. completion 2018-04-30 34 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT03158311

    Study to Compare QVM149 and Free Triple Combination of Salmeterol/Fluticasone + Tiotropium

    Not yet reported Novartis Pharmaceuticals 1426 participants Est. completion 2019-07-19 163 sites
    Other conditions: Asthma
    View official trial listing →
  • Status unknown NCT NCT03169504

    Effect of Acupuncture on Patients With Chronic Obstructive Pulmonary Disease

    Not yet reported Henan University of Traditional Chinese Medicine 150 participants Est. completion 2018-12 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03188120

    Specific Use-Result of Spiriva Respimat® in Asthmatics

    Boehringer Ingelheim 193 participants Est. completion 2018-11-08 1 site
    Other conditions: Asthma
    View official trial listing →
  • Terminated NCT NCT03199976

    Efficacy of Intermittent Tiotropium in Early Childhood Wheezing

    Not yet reported Helsinki University Central Hospital 80 participants Est. completion 2020-11-18 1 site
    Other conditions: Wheezy Bronchitis, Asthmatic Bronchitis, Wheezing, Obstruction Airway
    View official trial listing →
  • Status unknown NCT NCT03226145

    Reclassifying Constipation Using Imaging and Manometry

    Not yet reported University of Nottingham 120 participants Est. completion 2021-06 3 sites
    Other conditions: Constipation - Functional, Irritable Bowel Syndrome Characterized by Constipation
    View official trial listing →
  • Completed NCT NCT03238885

    Predicting Pathological Complete Response of Rectal Cancer With Magnetic Resonance(MR) Radiomics

    Sun Ying-Shi 538 participants Est. completion 2019-01-21 1 site
    Other conditions: Locally Advanced Rectal Cancer
    View official trial listing →
  • Completed NCT NCT03240575

    The ENERGITO® 2 Study Compares 2 Inhaled Medicines for Chronic Obstructive Pulmonary Disease (COPD). One Medicine is a Combination of Tiotropium and Olodaterol (Stiolto®) Taken Using the Respimat® Inhaler and the Other Medicine is a Combination of Fluticasone and Salmeterol Taken Using the Diskus

    Not yet reported Boehringer Ingelheim 302 participants Est. completion 2019-05-06 45 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03244488

    Mental Ability Challenge Study in Adults With and Without HIV

    Vanderbilt University Medical Center 22 participants Est. completion 2018-12 1 site
    Other conditions: HIV-1-infection, Aging, Premature, Cognitive Impairment, Memory Impairment, HIV-Associated Cognitive Motor Complex
    View official trial listing →
  • Completed NCT NCT03246581

    Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers

    Not yet reported Kindeva Drug Delivery 40 participants Est. completion 2018-05-03 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT03258749

    Efficiency of Twice Daily Formoterol Versus Once Daily Tiotropium in Patients With GOLD A/B COPD

    Not yet reported Huashan Hospital 120 participants Est. completion 2018-10-31 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT03270839

    Motion Sickness Medications and Vestibular Time Constant

    Not yet reported Medical Corps, Israel Defense Force 54 participants Est. completion 2020-01-01 1 site
    Other conditions: Drug Reaction
    View official trial listing →
  • Completed NCT NCT03302065

    Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference

    Not yet reported Solventum US LLC 38 participants Est. completion 2017-01
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03332056

    The Use of Belladonna and Opium Suppository in the Treatment of Postoperative Stent Pain

    Not yet reported University of Washington 71 participants Est. completion 2015-10
    Other conditions: Nephrolithiasis
    View official trial listing →
  • Completed NCT NCT03357393

    Patient-controlled Sedation With Propofol Versus Combined Sedation During Bronchoscopy

    Not yet reported Lena Nilsson 150 participants Est. completion 2017-05-09 Stand-alone
    Other conditions: Sedation, Bronchoscopy
    View official trial listing →
  • Completed NCT NCT03359655

    A Trial for Peroperative Procedure and Postoperative Pain After Rectal Misoprostol or Rectal Hyoscine Administration

    Not yet reported Bezmialem Vakif University 120 participants Est. completion 2018-12-13 1 site
    Other conditions: Hysteroscopic Surgery, Pain, Postoperative
    View official trial listing →
  • Completed NCT NCT03376295

    Comparative Effectiveness of COPD Treatments

    Boehringer Ingelheim 3954 participants Est. completion 2017-12-31 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Withdrawn NCT NCT03376932

    Effectiveness of Fluticasone Furoate/ Umeclidinium/ Vilanterol (FF/UMEC/VI) Using the Connected Inhaler System (CIS) as Compared With Fluticasone Proprionate/ Salmeterol (FP/SAL) Plus Tiotropium (TIO) in Inadequately Controlled Asthma

    Not yet reported GlaxoSmithKline Est. completion 2021-02-03
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT03386448

    The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression

    Not yet reported The Taub Group 14 participants Est. completion 2018-11-20 1 site Stand-alone
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT03395002

    Tiotropium/Salmeterol/Fluticasone Fixed Dose Combination Tratment Via Discair vs Tiotropium Via Handihaler + Salmeterol/Fluticasone Via Diskus Free Combination Treatment

    Not yet reported Neutec Ar-Ge San ve Tic A.Ş 58 participants Est. completion 2020-04-30 2 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT03430362

    Effect Of Intravenous Hyoscine -N-Butyl Bromide In Management Of Prolonged Labor In Nulliparous

    Not yet reported Cairo University 100 participants Est. completion 2020-02-16 1 site
    Other conditions: Prolonged Labor
    View official trial listing →
  • Completed NCT NCT03435003

    Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy

    Not yet reported Stony Brook University 83 participants Est. completion 2019-04-01 1 site Stand-alone
    Other conditions: Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy
    View official trial listing →
  • Completed NCT NCT03441217

    Hyoscine Butylbromide Effect on Duration of Labor

    Not yet reported Saint Thomas Hospital, Panama 218 participants Est. completion 2019-11-30 1 site
    Other conditions: Labor
    View official trial listing →
  • Completed NCT NCT03474081

    A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported GlaxoSmithKline 800 participants Est. completion 2019-07-17 72 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03478683

    A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported GlaxoSmithKline 729 participants Est. completion 2019-03-14 57 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03478696

    A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported GlaxoSmithKline 732 participants Est. completion 2019-03-18 57 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03499743

    Celecoxib Versus Hyoscine Butyl-bromide in Reducing Pain Associated With IUD.

    Not yet reported Cairo University 105 participants Est. completion 2018-09-05 1 site
    Other conditions: IUD Insertion Pain
    View official trial listing →
  • Completed NCT NCT03513250

    Efficacy of Hyoscine-n-butylbromide in Catheter-related Bladder Discomfort After Elective Cesarean Section.

    Not yet reported Cairo University 92 participants Est. completion 2020-07-15 1 site
    Other conditions: Catheter Related Bladder Discomfort
    View official trial listing →
  • Completed NCT NCT03541408

    Preventative Delirium Protocol in Elderly Patients

    Not yet reported Rush University Medical Center 263 participants Est. completion 2021-04-01 1 site Stand-alone
    Other conditions: Delirium
    View official trial listing →
  • Terminated NCT NCT03616067

    Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy

    Not yet reported Hospices Civils de Lyon 23 participants Est. completion 2025-09-22 11 sites
    Other conditions: Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT03673670

    Bronchodilator Effect of RPL554 Administered in Addition to Tiotropium/Olodaterol in Patients With COPD

    Not yet reported Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 79 participants Est. completion 2018-11-13 4 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT03698695

    A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers

    Not yet reported Theranexus 152 participants Est. completion 2019-12-20 7 sites
    Other conditions: Cognitive Impairment, Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT03745261

    Effect of Yong Chong Cao Capsule on Outcomes in Patients With Mild to Severe COPD

    Not yet reported Henan University of Traditional Chinese Medicine 240 participants Est. completion 2020-06 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Status unknown NCT NCT03842839

    Effect of Tiotropium on Airway Remodeling in Patients With Early Stage COPD Accessed by Optical Coherence Tomography

    Not yet reported Guangzhou Institute of Respiratory Disease 100 participants Est. completion 2022-12 1 site
    Other conditions: Airway Remodeling
    View official trial listing →
  • Status unknown NCT NCT03874130

    Scopolamine in Healthy Volunteers

    Not yet reported Repurposed Therapeutics, Inc. 130 participants Est. completion 2020-05 1 site
    Other conditions: Major Depressive Disorder (MDD)
    View official trial listing →
  • Status unknown NCT NCT03920644

    Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels

    Not yet reported Naval Aeromedical Research Unit, Dayton 320 participants Est. completion 2021-03 1 site Stand-alone
    Other conditions: Prevention of Nausea Associated With Motion Sickness, Treatment of Nausea Associated With Motion Sickness
    View official trial listing →
  • Completed NCT NCT03945344

    Effect of Charcoal on Gastrointestinal Absorption of Tiotropium

    Not yet reported Orion Corporation, Orion Pharma 20 participants Est. completion 2019-06-19 1 site
    Other conditions: Healthy Volunteer Study
    View official trial listing →
  • Completed NCT NCT03961165

    BUSCLAB - Buscopan to Prevent Slow Progress in Labor

    Not yet reported Oslo University Hospital 250 participants Est. completion 2022-06-16 1 site
    Other conditions: Labor (Obstetrics)--Complications, Labor; Prolonged, First Stage
    View official trial listing →
  • Completed NCT NCT03979807

    A Study Based on Medical Records That Looks at the Duration of Use of Two Types of Inhalers With Different Medicines in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Boehringer Ingelheim 11296 participants Est. completion 2019-06-11 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT03986905

    The Prevention and Treatment of Nausea Associated With Motion Sickness

    Not yet reported Repurposed Therapeutics, Inc. 300 participants Est. completion 2019-06-19 1 site Stand-alone
    Other conditions: Motion Sickness
    View official trial listing →
  • Completed NCT NCT03988530

    Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects

    Not yet reported Repurposed Therapeutics, Inc. 98 participants Est. completion 2020-11-23 1 site
    Other conditions: Motion Sickness
    View official trial listing →
  • Completed NCT NCT04008264

    A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery

    Alexander M Spiess, MD 74 participants Est. completion 2022-07-01 1 site
    Other conditions: Post Operative Pain Management
    View official trial listing →
  • Completed NCT NCT04011735

    Re-usable Respimat® Soft MistTM Inhaler Study

    Boehringer Ingelheim 262 participants Est. completion 2020-02-13 20 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT04061161

    Anti-inflammatory Effects of Tiotropium in Patients with Stable COPD

    Not yet reported University Medical Center Groningen 37 participants Est. completion 2023-12-31 2 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT04069078

    Hyoscine Butylbromide for Prevention of Bradycardia During Cesarean Section

    Not yet reported Assiut University 173 participants Est. completion 2020-02-25 1 site
    Other conditions: Bradycardia, Spinal Anesthetics Causing Adverse Effects in Therapeutic Use, Cesarean Section Complications
    View official trial listing →
  • Completed NCT NCT04081545

    Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery

    Not yet reported Christine Oryhan 181 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Opioid Use, Unspecified, Bariatric Surgery Candidate, Anesthesia
    View official trial listing →
  • Completed NCT NCT04125771

    Diclofenac Potassium Alone Versus Diclofenac Potassium With Hyoscine-N-butyl Bromide (HBB in Endoscopy

    Not yet reported Aljazeera Hospital 64 participants Est. completion 2020-10-01 1 site
    Other conditions: Pain
    View official trial listing →
  • Status unknown NCT NCT04137029

    Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers

    Not yet reported Federal State Budgetary Institution, Pulmonology Scientific Research Institute 20 participants Est. completion 2020-10 1 site
    Other conditions: Health, Subjective, Hyperreactivity, Bronchial
    View official trial listing →
  • Completed NCT NCT04138758

    Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS

    Boehringer Ingelheim 42953 participants Est. completion 2019-11-04 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT04179461

    Personalized Treatment Algorithms for Difficult-to-treat Asthma

    Not yet reported Children's Hospital Medical Center, Cincinnati 21 participants Est. completion 2019-10-03 1 site
    Other conditions: Asthma in Children
    View official trial listing →
  • Completed NCT NCT04184115

    Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness

    Not yet reported Repurposed Therapeutics, Inc. 102 participants Est. completion 2019-06-11 1 site Stand-alone
    Other conditions: Motion Sickness
    View official trial listing →
  • Completed NCT NCT04184297

    Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy

    Boehringer Ingelheim 27190 participants Est. completion 2019-11-04 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT04211961

    Scopolamine in Bipolar Depression

    Not yet reported Dr. Brian Hallahan 55 participants Est. completion 2024-02-22 1 site
    Other conditions: Bipolar Disorder Depression
    View official trial listing →
  • Terminated NCT NCT04219982

    DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness

    Not yet reported, Not yet reported Repurposed Therapeutics, Inc. 23 participants Est. completion 2019-01-28 1 site
    Other conditions: Motion Sickness
    View official trial listing →
  • Status unknown NCT NCT04231175

    Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal Cancer

    Not yet reported The Netherlands Cancer Institute 272 participants Est. completion 2023-10-28 1 site
    Other conditions: Colorectal Cancer, Peritoneal Carcinomatosis, MRI
    View official trial listing →
  • Completed NCT NCT04240626

    Multimodal Analgesia Effect on Post Surgical Patient

    Not yet reported University of California, Davis 60 participants Est. completion 2025-06-24 1 site Stand-alone
    Other conditions: Obesity, Morbid, Surgery, Bariatric Surgery Candidate
    View official trial listing →
  • Completed NCT NCT04249310

    Early Intervention Efficacy in COPD

    Boehringer Ingelheim 6788 participants Est. completion 2020-08-12 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Status unknown NCT NCT04272255

    Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness

    Not yet reported Repurposed Therapeutics, Inc. 300 participants Est. completion 2020-07 1 site Stand-alone
    Other conditions: Motion Sickness
    View official trial listing →
  • Terminated NCT NCT04314713

    A Study to Evaluate the Intramuscular Administration of Scopolamine

    Not yet reported Battelle Memorial Institute 32 participants Est. completion 2021-05-06 1 site
    Other conditions: Medical Countermeasures, Organophosphate Poisoning
    View official trial listing →
  • Completed NCT NCT04349722

    The Effect of Hyoscine-N-butylbromide (HBB, Buscopan) in Augmented Labour Among Primigravidae

    Not yet reported National University of Malaysia 110 participants Est. completion 2020-06-30 1 site
    Other conditions: Labor Long
    View official trial listing →
  • Status unknown NCT NCT04391361

    The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS

    Not yet reported Ruijin Hospital 30 participants Est. completion 2023-10-31 1 site Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis, Respiratory Function, Scopolamine
    View official trial listing →
  • Completed NCT NCT04520230

    Three Treatment of Chronic Obstructive Pulmonary Disease Patients

    Not yet reported Tanta University 45 participants Est. completion 2019-12-31
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT04552847

    Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

    Not yet reported, Not yet reported Universitaire Ziekenhuizen KU Leuven 85 participants Est. completion 2022-02-08 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Status unknown NCT NCT04593836

    Antiperistaltic Effect and Safety of L-menthol in the Elderly With Contraindication to Buscopan

    Not yet reported Taipei Veterans General Hospital, Taiwan 60 participants Est. completion 2020-12 1 site
    Other conditions: Upper Gastrointestinal Endoscopy
    View official trial listing →
  • Status unknown NCT NCT04630782

    Evaluating Gut Imaging and Stool Biomarkers in Patients With Scleroderma-associated Gastrointestinal Disease

    Singapore General Hospital 70 participants Est. completion 2023-01-31 5 sites
    Other conditions: Systemic Sclerosis, Scleroderma
    View official trial listing →
  • Withdrawn NCT NCT04666701

    Efficacy and Safety of Escócia Association in the Treatment of Acute Pain

    Not yet reported EMS Est. completion 2025-06 Stand-alone
    Other conditions: Acute Pain
    View official trial listing →
  • Completed NCT NCT04672941

    Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece

    Boehringer Ingelheim 1396 participants Est. completion 2022-02-21 2 sites
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT04682860

    Management of Abdominal Pain in Acute Gastroenteritis Patients With Hyoscine Butylbromide

    Not yet reported Ankara City Hospital Bilkent 50 participants Est. completion 2022-01-03 1 site
    Other conditions: Acute Gastroenteritis, Abdominal Pain
    View official trial listing →
  • Completed NCT NCT04719663

    The Modulatory Role of Communicated Treatment Rationale on Treatment Expectation Effects in Depression.

    Not yet reported Philipps University Marburg 150 participants Est. completion 2023-09-12 1 site
    Other conditions: Condition: Major Depressive Disorder (MDD)
    View official trial listing →
  • Status unknown NCT NCT04751084

    Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment

    Not yet reported Chinese University of Hong Kong 675 participants Est. completion 2024-09-14 1 site
    Other conditions: IVF, Intracytoplasmic Sperm Injection
    View official trial listing →
  • Completed NCT NCT04756232

    Cholinergic Mechanisms of Attention in Aging

    Not yet reported Vanderbilt University Medical Center 19 participants Est. completion 2025-05-01 1 site Stand-alone
    Other conditions: Subjective Cognitive Decline
    View official trial listing →
  • Completed NCT NCT04785118

    Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia

    Not yet reported Assiut University 165 participants Est. completion 2022-12-12 1 site
    Other conditions: Vomiting
    View official trial listing →
  • Completed NCT NCT04823065

    4FMFES-PET Imaging of Endometrial and Ovarian Cancers

    Not yet reported, Not yet reported Centre de recherche du Centre hospitalier universitaire de Sherbrooke 53 participants Est. completion 2024-04-30 1 site
    Other conditions: Endometrial Cancer, Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT04866355

    Lumbar Spine Manipulation Versus Pharmacological Therapy in Young Women With Primary Dysmenorrhea

    Not yet reported University of Alcala 42 participants Est. completion 2022-11-10 2 sites
    Other conditions: Women With Primary Dysmenorrhea
    View official trial listing →
  • Completed NCT NCT04926233

    Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study

    Boehringer Ingelheim 1371146 participants Est. completion 2020-04-14 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT04947423

    Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion

    Not yet reported Repurposed Therapeutics, Inc. 140 participants Est. completion 2021-08-12 1 site Stand-alone
    Other conditions: Motion Sickness
    View official trial listing →
  • Terminated NCT NCT04990167

    Tiotropium vs. Inhaled Corticosteroids in Children With Nonatopic Asthma Pilot Study (TioNAAP)

    Not yet reported Nemours Children's Clinic 11 participants Est. completion 2025-10-31 1 site
    Other conditions: Asthma in Children
    View official trial listing →
  • Not yet recruiting NCT NCT04993508

    Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging

    Not yet reported Heinrich-Heine University, Duesseldorf 1908 participants Est. completion 2030-03-31
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT04999449

    Nebulizer Delivery of Intranasal Scopolamine

    Not yet reported Dartmouth-Hitchcock Medical Center 14 participants Est. completion 2025-05-07 1 site Stand-alone
    Other conditions: Scopolamine, Motion Sickness
    View official trial listing →
  • Completed NCT NCT05021263

    Does IV Magnesium Improve Quality of Recovery With ERAS Protocols in Laparoscopic Colorectal Surgery?

    Not yet reported Thomas Jefferson University 90 participants Est. completion 2023-12-29 1 site Stand-alone
    Other conditions: Colo-rectal Cancer, Anesthesia
    View official trial listing →
  • Completed NCT NCT05083429

    Replication of the POET-COPD Trial in Healthcare Claims Data

    Brigham and Women's Hospital 8716 participants Est. completion 2021-08-09 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT05113615

    Regular Use Tiotropium and Tolerance to Bronchoprotection in Mild Asthma

    Not yet reported University of Saskatchewan 12 participants Est. completion 2022-05-06 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT05127304

    A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol

    Boehringer Ingelheim 11316 participants Est. completion 2022-02-03 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT05161156

    Bioequivalence Study of Tiotropium Bromide Inhalation Powder

    Not yet reported Phargentis SA 306 participants Est. completion 2022-11-29 17 sites
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT05165485

    Phase 4 COPD and Suboptimal Inspiratory Flow Rate

    Not yet reported Theravance Biopharma 404 participants Est. completion 2023-11-20 76 sites
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Completed NCT NCT05169424

    A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)

    Boehringer Ingelheim 9117 participants Est. completion 2021-12-27 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT05179512

    Replication of the INSPIRE Trial in Healthcare Claims Data

    Brigham and Women's Hospital 98278 participants Est. completion 2021-08-30 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Status unknown NCT NCT05222646

    Metoclopramide Versus Hyoscine Butylbromide in Shortening Duration of First Stage of Labour

    Not yet reported Uwakwe Emmanuel Chijioke 150 participants Est. completion 2022-08-30 1 site
    Other conditions: Duration of Labour
    View official trial listing →
  • Terminated NCT NCT05362487

    Assessment of Health-related Quality of Life After Switching COPD Patients From a Dry Powder Inhaler to a Soft Mist Inhaler Remaining on the Same Inhalative Drug

    Boehringer Ingelheim 9 participants Est. completion 2023-01-18 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Status unknown NCT NCT05375721

    Prevention of PONV With Traditional Chinese Medicine

    Not yet reported The Second Hospital of Anhui Medical University 300 participants Est. completion 2024-05-01 7 sites Stand-alone
    Other conditions: Postoperative Nausea and Vomiting
    View official trial listing →
  • Completed NCT NCT05402020

    Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan

    Boehringer Ingelheim 17018 participants Est. completion 2023-02-13 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT05501639

    Exacerbation Risk in Asthma

    Boehringer Ingelheim 1899 participants Est. completion 2021-11-02 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT05506865

    Efficacy and Safety of Indacaterol vs Tiotropium in Women With COPD Secondary to Biomass Exposure

    Not yet reported National Institute of Respiratory Diseases, Mexico 73 participants Est. completion 2016-07 1 site
    Other conditions: COPD
    View official trial listing →
  • Completed NCT NCT05548270

    Efficacy and Safety of DPI-386 Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion

    Not yet reported Repurposed Therapeutics, Inc. 503 participants Est. completion 2022-11-29 1 site Stand-alone
    Other conditions: Motion Sickness
    View official trial listing →
  • Withdrawn NCT NCT05838703

    Tiotropium Handihaler vs. Tiotropium Respimat in COPD

    Not yet reported Duke University Est. completion 2024-05-01
    Other conditions: Chronic Obstructive Pulmonary Disease (COPD)
    View official trial listing →
  • Status unknown NCT NCT05886660

    Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance

    Not yet reported Repurposed Therapeutics, Inc. 30 participants Est. completion 2024-09 1 site
    Other conditions: Motion Sickness, Space, Motion Sickness, Sea Sickness
    View official trial listing →
  • Status unknown NCT NCT05911126

    How to Reduce Pain in Patients Undergoing Office Hysteroscopy.

    Not yet reported Cairo University 180 participants Est. completion 2023-12-13
    Other conditions: Pain
    View official trial listing →
  • Status unknown NCT NCT05913310

    Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia

    Not yet reported Quan Jiang 126 participants Est. completion 2024-08
    Other conditions: Hyperuricemia
    View official trial listing →
  • Completed NCT NCT05927155

    Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD

    Not yet reported Erasme University Hospital 30 participants Est. completion 2022-03-30 1 site
    Other conditions: Pulmonary Disease, Chronic Obstructive
    View official trial listing →
  • Completed NCT NCT05939635

    M-Tapa Block vs External Oblique Intercostal Block for Laparoscopic Sleeve Gastrectomy Surgery

    Not yet reported Ondokuz Mayıs University 66 participants Est. completion 2024-01-29 1 site
    Other conditions: Anesthesia, Regional Anesthesia, Postoperative Pain
    View official trial listing →
  • Completed NCT NCT05986591

    Bioequivalence Study of Tiotropium 18 μg Inhalation Powder, Hard Capsule With Spiriva®Handihaler® 18 μg Inhalation Powder, Hard Capsule in Patients With Chronic Obstructive Pulmonary Disease (COPD)

    Not yet reported Xiromed LLC 335 participants Est. completion 2023-08-14 33 sites
    Other conditions: COPD
    View official trial listing →
  • Withdrawn NCT NCT06014385

    PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor

    Not yet reported Yale University Est. completion 2025-07-01 1 site Stand-alone
    Other conditions: Muscarinic Receptor Occupancy
    View official trial listing →
  • Status unknown NCT NCT06056869

    Effect of Hyoscine- Bromide on Duration of the First Stage of Labor

    Not yet reported Ain Shams University 60 participants Est. completion 2024-04 1 site
    Other conditions: Labor
    View official trial listing →
  • Completed NCT NCT06207539

    Induction of Abortion in the Second Trimester

    Not yet reported Ain Shams Maternity Hospital 40 participants Est. completion 2023-04-30 1 site
    Other conditions: Abortion, Second Trimester
    View official trial listing →
  • Completed NCT NCT06254664

    Open Label Study to Assess the Effect of Patient Use and Robustness of Tiotropium 18ug Inhalation Powder, Hard Capsule,Zephir Inhaler Device

    Not yet reported Xiromed LLC 116 participants Est. completion 2023-10-27 9 sites
    Other conditions: COPD
    View official trial listing →
  • Terminated NCT NCT06282861

    ANTES B+ Clinical Trial

    Not yet reported Fundacio Privada Mon Clinic Barcelona 48 participants Est. completion 2025-01-23 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Not yet recruiting NCT NCT06398054

    A Study to Investigate the Analgesic Efficacy of Ibuprofen Alone and Ibuprofen Plus Hyoscine-n- Butyl Bromide in Reducing Pain of Outpatient Hysteroscopy

    Not yet reported ASST Fatebenefratelli Sacco 190 participants Est. completion 2026-10-01
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT06525051

    Effect of Tiotropium on Eye Findings in the Treatment of Chronic Obstructive Pulmonary Disease

    Giresun University 108 participants Est. completion 2024-04-30 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease, Glaucoma, Angle-Closure
    View official trial listing →
  • Not yet recruiting NCT NCT06679465

    Evaluating the Impact of Single Dose Tiotropium on Allergen-induced Early Asthmatic Response

    Not yet reported University of Saskatchewan 10 participants Est. completion 2027-01 1 site
    Other conditions: Asthma Bronchiale
    View official trial listing →
  • Completed NCT NCT06927817

    The Effect of Hyoscine-n-butylbromide on Nausea and Pain in Laparoscopic Cholecystectomy

    Not yet reported Saglik Bilimleri Universitesi 134 participants Est. completion 2025-04-08 1 site
    Other conditions: Cholecystitis, Pain, Nausea
    View official trial listing →
  • Terminated NCT NCT07267130

    A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TQC3302 Inhalation Spray in Healthy Adult Subjects

    Not yet reported Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd. 33 participants Est. completion 2026-08-21 1 site
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07271303

    A Clinical Study to Evaluate the Efficacy and Safety of Hyoscine Butylbromide Capsules for Preoperative Preparation in Painless Gastrointestinal Endoscopy Procedures

    Not yet reported Shanghai Jiao Tong University School of Medicine 74 participants Est. completion 2026-12-01
    Other conditions: Painless Gastrointestinal Endoscopy
    View official trial listing →
  • Completed NCT NCT07383571

    Oral Hyoscine vs Lidocaine-Prilocaine Spray vs Placebo for HSG Pain Relief

    Not yet reported Cairo University 102 participants Est. completion 2026-04-30 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Enrolling by invitation NCT NCT07423923

    Representation of Spatiotemporal Information in Human Episodic Memory and Navigation

    Not yet reported University of Arizona 15 participants Est. completion 2030-03-29 2 sites Stand-alone
    Other conditions: Scopolamine or Placebo, Schema to Organize Memory or no Schema
    View official trial listing →
  • Completed NCT NCT07474350

    Valethamate Bromide Versus Hyoscine Butyl Bromide in Reducing Labour Duration Among Primigravida

    Not yet reported Federal Teaching Hospital Abakaliki 165 participants Est. completion 2024-01-23 1 site
    Other conditions: Labour Duration, Primigravida
    View official trial listing →
  • Suspended NCT NCT07541378

    Comparative Efficacy of Once-daily LAMA/LABA Combinations Versus Tiotropium on Constant-work-rate Cycle Endurance in COPD

    Not yet reported Medical University of Bialystok 100 participants Est. completion 2027-09-01 1 site
    Other conditions: COPD (Chronic Obstructive Pulmonary Disease)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Scopolamine patch, Scopolamine

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.